{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T23:33:00Z","timestamp":1772148780528,"version":"3.50.1"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,3,22]],"date-time":"2018-03-22T00:00:00Z","timestamp":1521676800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"SJTU Medicine-Engineering Cross-disciplinary Research Foundation","award":["YG2016QN62"],"award-info":[{"award-number":["YG2016QN62"]}]},{"name":"Guangci Excellent Youth Program","award":["GCQN-2017-B04"],"award-info":[{"award-number":["GCQN-2017-B04"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81671589"],"award-info":[{"award-number":["81671589"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81601400"],"award-info":[{"award-number":["81601400"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Shanghai Sailing Program","award":["16YF1407000"],"award-info":[{"award-number":["16YF1407000"]}]},{"DOI":"10.13039\/501100003399","name":"Science and Technology Commission of Shanghai Municipality","doi-asserted-by":"publisher","award":["17411965100"],"award-info":[{"award-number":["17411965100"]}],"id":[{"id":"10.13039\/501100003399","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arthritis Res Ther"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s13075-018-1555-6","type":"journal-article","created":{"date-parts":[[2018,4,4]],"date-time":"2018-04-04T04:41:44Z","timestamp":1522816904000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":35,"title":["Interleukin-37 is increased in adult-onset Still\u2019s disease and associated with disease activity"],"prefix":"10.1186","volume":"20","author":[{"given":"Huihui","family":"Chi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dongzhou","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yue","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiongyi","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Honglei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaobing","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junna","family":"Ye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yufeng","family":"Yin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mengru","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinyao","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhuochao","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jialin","family":"Teng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chengde","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yutong","family":"Su","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,3,22]]},"reference":[{"issue":"2","key":"1555_CR1","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.berh.2016.08.003","volume":"30","author":"S Casta\u00f1eda","year":"2016","unstructured":"Casta\u00f1eda S, Blanco R, Gonz\u00e1lez-Gay MA. Adult-onset Still\u2019s disease: advances in the treatment. Best Pract Res Clin Rheumatol. 2016;30(2):222\u201338.","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"1555_CR2","doi-asserted-by":"crossref","unstructured":"Kadavath S, Efthimiou P. Adult-onset Still\u2019s disease-pathogenesis, clinical manifestations, and new treatment options. Ann Med 2015;47(1):6\u201314.","DOI":"10.3109\/07853890.2014.971052"},{"issue":"7","key":"1555_CR3","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1016\/j.autrev.2014.01.058","volume":"13","author":"M Gerfaud-Valentin","year":"2014","unstructured":"Gerfaud-Valentin M, Jamilloux Y, Iwaz J, S\u00e8ve P. Adult-onset Still\u2019s disease. Autoimmun Rev. 2014;13(7):708\u201322.","journal-title":"Autoimmun Rev"},{"issue":"5","key":"1555_CR4","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1016\/j.berh.2008.08.006","volume":"22","author":"B Fautrel","year":"2008","unstructured":"Fautrel B. Adult-onset Still disease. Best Pract Res Clin Rheumatol. 2008;22(5):773\u201392.","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"1555_CR5","doi-asserted-by":"publisher","first-page":"964751","DOI":"10.1155\/2012\/964751","volume":"2012","author":"P Efthimiou","year":"2012","unstructured":"Efthimiou P, Moorthy LN, Mavragani CP, Skokos D, Fautrel B. Adult onset Still\u2019s disease and autoinflammation. Int J Inflamm. 2012;2012:964751.","journal-title":"Int J Inflamm"},{"issue":"9","key":"1555_CR6","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1136\/ard.47.9.764","volume":"47","author":"JM Wouters","year":"1988","unstructured":"Wouters JM, van der Veen J, van de Putte LB, de Rooij DJ. Adult onset Still\u2019s disease and viral infections. Ann Rheum Dis. 1988;47(9):764\u20137.","journal-title":"Ann Rheum Dis"},{"issue":"8855","key":"1555_CR7","doi-asserted-by":"publisher","first-page":"1280","DOI":"10.1016\/0140-6736(93)91184-N","volume":"341","author":"J Pouchot","year":"1993","unstructured":"Pouchot J, Ouakil H, Debin ML, Vinceneux P. Adult Still\u2019s disease associated with acute human parvovirus B19 infection. Lancet. 1993;341(8855):1280\u20131.","journal-title":"Lancet"},{"issue":"11","key":"1555_CR8","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1016\/j.autrev.2014.08.032","volume":"13","author":"AT Maria","year":"2014","unstructured":"Maria AT, Le Quellec A, Jorgensen C, Touitou I, Rivi\u00e8re S, Guilpain P. Adult onset Still\u2019s disease (AOSD) in the era of biologic therapies: dichotomous view for cytokine and clinical expressions. Autoimmun Rev. 2014;13(11):1149\u201359.","journal-title":"Autoimmun Rev"},{"issue":"7","key":"1555_CR9","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1038\/sj.gene.6363922","volume":"3","author":"T Sugiura","year":"2002","unstructured":"Sugiura T, Kawaguchi Y, Harigai M, Terajima-Ichida H, Kitamura Y, Furuya T, Ichikawa N, Kotake S, Tanaka M, Hara M, et al. Association between adult-onset Still\u2019s disease and interleukin-18 gene polymorphisms. Genes Immun. 2002;3(7):394\u20139.","journal-title":"Genes Immun"},{"issue":"3","key":"1555_CR10","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1002\/1529-0131(200103)44:3<550::AID-ANR103>3.0.CO;2-5","volume":"44","author":"M Kawashima","year":"2001","unstructured":"Kawashima M, Yamamura M, Taniai M, Yamauchi H, Tanimoto T, Kurimoto M, Miyawaki S, Amano T, Takeuchi T, Makino H. Levels of interleukin-18 and its binding inhibitors in the blood circulation of patients with adult-onset Still\u2019s disease. Arthritis Rheum. 2001;44(3):550\u201360.","journal-title":"Arthritis Rheum"},{"issue":"7","key":"1555_CR11","doi-asserted-by":"publisher","first-page":"1716","DOI":"10.1002\/1529-0131(200107)44:7<1716::AID-ART298>3.0.CO;2-I","volume":"44","author":"Y Kawaguchi","year":"2001","unstructured":"Kawaguchi Y, Terajima H, Harigai M, Hara M, Kamatani N. Interleukin-18 as a novel diagnostic marker and indicator of disease severity in adult-onset Still\u2019s disease. Arthritis Rheum. 2001;44(7):1716\u20137.","journal-title":"Arthritis Rheum"},{"issue":"2","key":"1555_CR12","first-page":"396","volume":"25","author":"T Hoshino","year":"1998","unstructured":"Hoshino T, Ohta A, Yang D, Kawamoto M, Kikuchi M, Inoue Y, Kamizono S, Ota T, Itoh K, Oizumi K. Elevated serum interleukin 6, interferon-\u03b3, and tumor necrosis factor-\u03b1 levels in patients with adult Still\u2019s disease. J Rheumatol. 1998;25(2):396\u20138.","journal-title":"J Rheumatol"},{"key":"1555_CR13","doi-asserted-by":"publisher","first-page":"156890","DOI":"10.1155\/2012\/156890","volume":"2012","author":"S Colafrancesco","year":"2012","unstructured":"Colafrancesco S, Priori R, Alessandri C, Perricone C, Pendolino M, Picarelli G, Valesini G. IL-18 serum level in adult onset Still\u2019s disease: a marker of disease activity. Int J Inflamm. 2012;2012:156890.","journal-title":"Int J Inflamm"},{"key":"1555_CR14","doi-asserted-by":"publisher","first-page":"317820","DOI":"10.1155\/2012\/317820","volume":"2012","author":"C Giampietro","year":"2012","unstructured":"Giampietro C, Fautrel B. Anti-interleukin-1 agents in adult onset Still\u2019s disease. Int J Inflamm. 2012;2012:317820.","journal-title":"Int J Inflamm"},{"issue":"1","key":"1555_CR15","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/s10067-013-2381-5","volume":"33","author":"P Cipriani","year":"2014","unstructured":"Cipriani P, Ruscitti P, Carubbi F, Pantano I, Liakouli V, Berardicurti O, Giacomelli R. Tocilizumab for the treatment of adult-onset Still\u2019s disease: results from a case series. Clin Rheumatol. 2014;33(1):49\u201355.","journal-title":"Clin Rheumatol"},{"issue":"2","key":"1555_CR16","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.semarthrit.2012.03.004","volume":"42","author":"A Kontzias","year":"2012","unstructured":"Kontzias A, Efthimiou P. The use of canakinumab, a novel IL-1\u03b2 long-acting inhibitor, in refractory adult-onset Still\u2019s disease. Semin Arthritis Rheum. 2012;42(2):201\u20135.","journal-title":"Semin Arthritis Rheum"},{"issue":"39","key":"1555_CR17","doi-asserted-by":"publisher","first-page":"e1554","DOI":"10.1097\/MD.0000000000001554","volume":"94","author":"F Ortiz-Sanju\u00e1n","year":"2015","unstructured":"Ortiz-Sanju\u00e1n F, Blanco R, Riancho-Zarrabeitia L, Casta\u00f1eda S, Oliv\u00e9 A, Riveros A, Velloso-Feijoo ML, Narv\u00e1ez J, Jim\u00e9nez-Mole\u00f3n I, Maiz-Alonso O, et al. Efficacy of anakinra in refractory adult-onset Still\u2019s disease: multicenter study of 41 patients and literature review. Medicine (Baltimore). 2015;94(39):e1554.","journal-title":"Medicine (Baltimore)"},{"issue":"11","key":"1555_CR18","first-page":"2189","volume":"31","author":"DY Chen","year":"2004","unstructured":"Chen DY, Lan JL, Lin FJ, Hsieh TY. Proinflammatory cytokine profiles in sera and pathological tissues of patients with active untreated adult onset Still\u2019s disease. J Rheumatol. 2004;31(11):2189\u201398.","journal-title":"J Rheumatol"},{"issue":"12","key":"1555_CR19","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.1093\/rheumatology\/40.12.1398","volume":"40","author":"T Fujii","year":"2001","unstructured":"Fujii T, Nojima T, Yasuoka H, Satoh S, Nakamura K, Kuwana M, Suwa A, Hirakata M, Mimori T. Cytokine and immunogenetic profiles in Japanese patients with adult Still\u2019s disease: association with chronic articular disease. Rheumatology (Oxford). 2001;40(12):1398\u2013404.","journal-title":"Rheumatology (Oxford)"},{"issue":"4","key":"1555_CR20","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1002\/acr.22194","volume":"66","author":"H Ichida","year":"2014","unstructured":"Ichida H, Kawaguchi Y, Sugiura T, Takagi K, Katsumata Y, Gono T, Ota Y, Kataoka S, Kawasumi H, Yamanaka H. Clinical manifestations of Adult-onset Still\u2019s disease presenting with erosive arthritis: association with low levels of ferritin and interleukin-18. Arthritis Care Res. 2014;66(4):642\u20136.","journal-title":"Arthritis Care Res"},{"issue":"10","key":"1555_CR21","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1016\/j.autrev.2017.07.017","volume":"16","author":"M Govoni","year":"2017","unstructured":"Govoni M, Bortoluzzi A, Rossi D, Modena V. How I treat patients with adult onset Still\u2019s disease in clinical practice. Autoimmun Rev. 2017;16(10):1016\u201323.","journal-title":"Autoimmun Rev"},{"issue":"4","key":"1555_CR22","doi-asserted-by":"publisher","first-page":"309","DOI":"10.3109\/03009742.2014.992949","volume":"44","author":"G Cavalli","year":"2015","unstructured":"Cavalli G, Franchini S, Aiello P, Guglielmi B, Berti A, Campochiaro C, Sabbadini MG, Baldissera E, Dagna L. Efficacy and safety of biological agents in adult-onset Still\u2019s disease. Scand J Rheumatol. 2015;44(4):309\u201314.","journal-title":"Scand J Rheumatol"},{"key":"1555_CR23","doi-asserted-by":"publisher","first-page":"369","DOI":"10.3389\/fphar.2017.00369","volume":"8","author":"S Colafrancesco","year":"2017","unstructured":"Colafrancesco S, Priori R, Valesini G, Argolini L, Baldissera E, Bartoloni E, Cammelli D, Canestrari G, Cantarini L, Cavallaro E, et al. Response to interleukin-1 inhibitors in 140 Italian patients with adult-onset Still\u2019s disease: a multicentre retrospective observational study. Front Pharmacol. 2017;8:369.","journal-title":"Front Pharmacol"},{"key":"1555_CR24","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/1479-5876-12-69","volume":"12","author":"L Ye","year":"2014","unstructured":"Ye L, Ji L, Wen Z, Zhou Y, Hu D, Li Y, Yu T, Chen B, Zhang J, Ding L, et al. IL-37 inhibits the production of inflammatory cytokines in peripheral blood mononuclear cells of patients with systemic lupus erythematosus: its correlation with disease activity. J Transl Med. 2014;12:69.","journal-title":"J Transl Med"},{"issue":"2","key":"1555_CR25","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1016\/j.cyto.2015.06.005","volume":"76","author":"L Xia","year":"2015","unstructured":"Xia L, Shen H, Lu J. Elevated serum and synovial fluid levels of interleukin-37 in patients with rheumatoid arthritis: attenuated the production of inflammatory cytokines. Cytokine. 2015;76(2):553\u20137.","journal-title":"Cytokine"},{"issue":"11","key":"1555_CR26","doi-asserted-by":"publisher","first-page":"5110","DOI":"10.4049\/jimmunol.1401810","volume":"194","author":"L Ye","year":"2015","unstructured":"Ye L, Jiang B, Deng J, Du J, Xiong W, Guan Y, Wen Z, Huang K, Huang Z. IL-37 alleviates rheumatoid arthritis by suppressing IL-17 and IL-17-triggering cytokine production and limiting Th17 cell proliferation. J Immunol. 2015;194(11):5110\u20139.","journal-title":"J Immunol"},{"issue":"12","key":"1555_CR27","doi-asserted-by":"publisher","first-page":"2220","DOI":"10.1093\/rheumatology\/kew325","volume":"55","author":"G Cavalli","year":"2016","unstructured":"Cavalli G, Koenders M, Kalabokis V, Kim J, Tan AC, Garlanda C, Mantovani A, Dagna L, Joosten LA, Dinarello CA. Treating experimental arthritis with the innate immune inhibitor interleukin-37 reduces joint and systemic inflammation. Rheumatology (Oxford). 2016;55(12):2220\u20139.","journal-title":"Rheumatology (Oxford)"},{"key":"1555_CR28","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s12967-015-0394-3","volume":"13","author":"B Chen","year":"2015","unstructured":"Chen B, Huang K, Ye L, Li Y, Zhang J, Zhang J, Fan X, Liu X, Li L, Sun J, et al. Interleukin-37 is increased in ankylosing spondylitis patients and associated with disease activity. J Transl Med. 2015;13:36.","journal-title":"J Transl Med"},{"issue":"1","key":"1555_CR29","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1111\/imr.12605","volume":"281","author":"G Cavalli","year":"2018","unstructured":"Cavalli G, Dinarello CA. Suppression of inflammation and acquired immunity by IL-37. Immunol Rev. 2018;281(1):179\u201390.","journal-title":"Immunol Rev"},{"issue":"5","key":"1555_CR30","doi-asserted-by":"publisher","first-page":"e95346","DOI":"10.1371\/journal.pone.0095346","volume":"9","author":"PW Zhao","year":"2014","unstructured":"Zhao PW, Jiang WG, Wang L, Jiang ZY, Shan YX, Jiang YF. Plasma levels of IL-37 and correlation with TNF-\u03b1, IL-17A, and disease activity during DMARD treatment of rheumatoid arthritis. PLoS One. 2014;9(5):e95346.","journal-title":"PLoS One"},{"issue":"11","key":"1555_CR31","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1038\/ni.1944","volume":"11","author":"MF Nold","year":"2010","unstructured":"Nold MF, Nold-Petry CA, Zepp JA, Palmer BE, Bufler P, Dinarello CA. IL-37 is a fundamental inhibitor of innate immunity. Nat Immunol. 2010;11(11):1014\u201322.","journal-title":"Nat Immunol"},{"issue":"3","key":"1555_CR32","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1684\/ecn.2011.0288","volume":"22","author":"D Boraschi","year":"2011","unstructured":"Boraschi D, Lucchesi D, Hainzl S, Leitner M, Maier E, Mangelberger D, Oostingh GJ, Pfaller T, Pixner C, Posselt G, et al. IL-37: a new anti-inflammatory cytokine of the IL-1 family. Eur Cytokine Netw. 2011;22(3):127\u201347.","journal-title":"Eur Cytokine Netw"},{"issue":"5","key":"1555_CR33","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1073\/pnas.1523212113","volume":"113","author":"M Coll-Mir\u00f3","year":"2016","unstructured":"Coll-Mir\u00f3 M, Francos-Quijorna I, Santos-Nogueira E, Torres-Espin A, Bufler P, Dinarello CA, L\u00f3pez-Vales R. Beneficial effects of IL-37 after spinal cord injury in mice. Proc Natl Acad Sci U S A. 2016;113(5):1411\u20136.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"9","key":"1555_CR34","doi-asserted-by":"publisher","first-page":"2313","DOI":"10.1073\/pnas.1619011114","volume":"114","author":"G Cavalli","year":"2017","unstructured":"Cavalli G, Justice JN, Boyle KE, D\u2019Alessandro A, Eisenmesser EZ, Herrera JJ, Hansen KC, Nemkov T, Stienstra R, Garlanda C, et al. Interleukin 37 reverses the metabolic cost of inflammation, increases oxidative respiration, and improves exercise tolerance. Proc Natl Acad Sci U S A. 2017;114(9):2313\u20138.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7","key":"1555_CR35","doi-asserted-by":"publisher","first-page":"1631","DOI":"10.1073\/pnas.1619667114","volume":"114","author":"Q Zeng","year":"2017","unstructured":"Zeng Q, Song R, Fullerton DA, Ao L, Zhai Y, Li S, Ballak DB, Cleveland JC Jr, Reece TB, McKinsey TA, et al. Interleukin-37 suppresses the osteogenic responses of human aortic valve interstitial cells in vitro and alleviates valve lesions in mice. Proc Natl Acad Sci U S A. 2017;114(7):1631\u20136.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"9","key":"1555_CR36","doi-asserted-by":"publisher","first-page":"e107183","DOI":"10.1371\/journal.pone.0107183","volume":"9","author":"Y Li","year":"2014","unstructured":"Li Y, Wang Z, Yu T, Chen B, Zhang J, Huang K, Huang Z. Increased expression of IL-37 in patients with Graves\u2019 disease and its contribution to suppression of proinflammatory cytokines production in peripheral blood mononuclear cells. PLoS One. 2014;9(9):e107183.","journal-title":"PLoS One"},{"issue":"3","key":"1555_CR37","first-page":"424","volume":"19","author":"M Yamaguchi","year":"1992","unstructured":"Yamaguchi M, Ohta A, Tsunematsu T, Kasukawa R, Mizushima Y, Kashiwagi H, Kashiwazaki S, Tanimoto K, Matsumoto Y, Ota T, et al. Preliminary criteria for classification of adult Still\u2019s disease. J Rheumatol. 1992;19(3):424\u201330.","journal-title":"J Rheumatol"},{"issue":"2","key":"1555_CR38","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1097\/00005792-199103000-00004","volume":"70","author":"J Pouchot","year":"1991","unstructured":"Pouchot J, Sampalis JS, Beaudet F, Carette S, Decary F, Salusinsky-Sternbach M, Hill RO, Gutkowski A, Harth M, Myhal D, et al. Adult Still\u2019s disease: manifestations, disease course, and outcome in 62 patients. Medicine (Baltimore). 1991;70(2):118\u201336.","journal-title":"Medicine (Baltimore)"},{"issue":"11","key":"1555_CR39","doi-asserted-by":"publisher","first-page":"2369","DOI":"10.3899\/jrheum.100247","volume":"37","author":"M Rau","year":"2010","unstructured":"Rau M, Schiller M, Krienke S, Heyder P, Lorenz H, Blank N. Clinical manifestations but not cytokine profiles differentiate adult-onset Still\u2019s disease and sepsis. J Rheumatol. 2010;37(11):2369\u201376.","journal-title":"J Rheumatol"},{"issue":"12","key":"1555_CR40","doi-asserted-by":"publisher","first-page":"2237","DOI":"10.1093\/rheumatology\/kew300","volume":"55","author":"C Girard","year":"2016","unstructured":"Girard C, Rech J, Brown M, Allali D, Roux-Lombard P, Spertini F, Schiffrin EJ, Schett G, Manger B, Bas S, et al. Elevated serum levels of free interleukin-18 in adult-onset Still\u2019s disease. Rheumatology (Oxford). 2016;55(12):2237\u201347.","journal-title":"Rheumatology (Oxford)"},{"issue":"5","key":"1555_CR41","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1089\/bio.2015.0104","volume":"14","author":"HW Grievink","year":"2016","unstructured":"Grievink HW, Luisman T, Kluft C, Moerland M, Malone KE. Comparison of three isolation techniques for human peripheral blood mononuclear cells: cell recovery and viability, population composition, and cell functionality. Biopreserv Biobank. 2016;14(5):410\u20135.","journal-title":"Biopreserv Biobank"},{"issue":"12","key":"1555_CR42","doi-asserted-by":"publisher","first-page":"4782","DOI":"10.1210\/en.2016-1167","volume":"157","author":"Y Su","year":"2016","unstructured":"Su Y, Jiang X, Li Y, Li F, Cheng Y, Peng Y, Song D, Hong J, Ning G, Cao Y, et al. Maternal low protein isocaloric diet suppresses pancreatic \u03b2-cell proliferation in mouse offspring via miR-15b. Endocrinology. 2016;157(12):4782\u201393.","journal-title":"Endocrinology"},{"issue":"1","key":"1555_CR43","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1093\/rheumatology\/ket250","volume":"53","author":"IA Al-Homood","year":"2014","unstructured":"Al-Homood IA. Biologic treatments for adult-onset Still\u2019s disease. Rheumatology (Oxford). 2014;53(1):32\u20138.","journal-title":"Rheumatology (Oxford)"},{"issue":"12","key":"1555_CR44","doi-asserted-by":"publisher","first-page":"2305","DOI":"10.1093\/rheumatology\/keq284","volume":"49","author":"DY Chen","year":"2010","unstructured":"Chen DY, Chen YM, Lan JL, Lin CC, Chen HH, Hsieh CW. Potential role of Th17 cells in the pathogenesis of adult-onset Still\u2019s disease. Rheumatology (Oxford). 2010;49(12):2305\u201312.","journal-title":"Rheumatology (Oxford)"},{"key":"1555_CR45","doi-asserted-by":"publisher","first-page":"879020","DOI":"10.1155\/2012\/879020","volume":"2012","author":"CP Mavragani","year":"2012","unstructured":"Mavragani CP, Spyridakis EG, Koutsilieris M. Adult-onset Still\u2019s disease: from pathophysiology to targeted therapies. Int J Inflamm. 2012;2012:879020.","journal-title":"Int J Inflamm"},{"issue":"2","key":"1555_CR46","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1002\/art.1780300209","volume":"30","author":"JJ Cush","year":"1987","unstructured":"Cush JJ, Medsger TA Jr, Christy WC, Herbert DC, Cooperstein LA. Adult-onset Still\u2019s disease: clinical course and outcome. Arthritis Rheum. 1987;30(2):186\u201394.","journal-title":"Arthritis Rheum"},{"issue":"9","key":"1555_CR47","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.1093\/rheumatology\/keq133","volume":"49","author":"M Shimizu","year":"2010","unstructured":"Shimizu M, Yokoyama T, Yamada K, Kaneda H, Wada H, Wada T, Toma T, Ohta K, Kasahara Y, Yachie A. Distinct cytokine profiles of systemic-onset juvenile idiopathic arthritis-associated macrophage activation syndrome with particular emphasis on the role of interleukin-18 in its pathogenesis. Rheumatology (Oxford). 2010;49(9):1645\u201353.","journal-title":"Rheumatology (Oxford)"},{"issue":"2","key":"1555_CR48","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.cyto.2012.11.025","volume":"61","author":"M Shimizu","year":"2013","unstructured":"Shimizu M, Nakagishi Y, Yachie A. Distinct subsets of patients with systemic juvenile idiopathic arthritis based on their cytokine profiles. Cytokine. 2013;61(2):345\u20138.","journal-title":"Cytokine"},{"issue":"10","key":"1555_CR49","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1136\/ard.2003.013680","volume":"63","author":"DY Chen","year":"2004","unstructured":"Chen DY, Lan JL, Lin FJ, Hsieh TY, Wen MC. Predominance of Th1 cytokine in peripheral blood and pathological tissues of patients with active untreated adult onset Still\u2019s disease. Ann Rheum Dis. 2004;63(10):1300\u20136.","journal-title":"Ann Rheum Dis"},{"issue":"11","key":"1555_CR50","first-page":"2422","volume":"30","author":"JH Choi","year":"2003","unstructured":"Choi JH, Suh CH, Lee YM, Suh YJ, Lee SK, Kim SS, Nahm DH, Park HS. Serum cytokine profiles in patients with adult onset Still\u2019s disease. J Rheumatol. 2003;30(11):2422\u20137.","journal-title":"J Rheumatol"},{"issue":"3","key":"1555_CR51","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1111\/cei.12061","volume":"172","author":"H Imaeda","year":"2013","unstructured":"Imaeda H, Takahashi K, Fujimoto T, Kasumi E, Ban H, Bamba S, Sonoda H, Shimizu T, Fujiyama Y, Andoh A. Epithelial expression of interleukin-37b in inflammatory bowel disease. Clin Exp Immunol. 2013;172(3):410\u20136.","journal-title":"Clin Exp Immunol"},{"issue":"11","key":"1555_CR52","doi-asserted-by":"publisher","first-page":"3793","DOI":"10.1002\/art.22981","volume":"56","author":"N Fall","year":"2007","unstructured":"Fall N, Barnes M, Thornton S, Luyrink L, Olson J, Ilowite NT, Gottlieb BS, Griffin T, Sherry DD, Thompson S, et al. Gene expression profiling of peripheral blood from patients with untreated new-onset systemic juvenile idiopathic arthritis reveals molecular heterogeneity that may predict macrophage activation syndrome. Arthritis Rheum. 2007;56(11):3793\u2013804.","journal-title":"Arthritis Rheum"},{"issue":"4","key":"1555_CR53","doi-asserted-by":"publisher","first-page":"407","DOI":"10.3109\/s10165-008-0065-9","volume":"18","author":"T Ito","year":"2008","unstructured":"Ito T, Ozaki Y, Shimamoto K, Amuro H, Tanijiri T, Yokoi T, Son Y, Tajima K, Fukuhara S. Successful treatment with plasma exchange in adult-onset Still\u2019s disease with hyper-IL-18-naemia and hyperallergic state. Mod Rheumatol. 2008;18(4):407\u201310.","journal-title":"Mod Rheumatol"},{"issue":"7","key":"1555_CR54","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1038\/nrrheum.2011.68","volume":"7","author":"ED Mellins","year":"2011","unstructured":"Mellins ED, Macaubas C, Grom AA. Pathogenesis of systemic juvenile idiopathic arthritis: some answers, more questions. Nat Rev Rheumatol. 2011;7(7):416\u201326.","journal-title":"Nat Rev Rheumatol"},{"issue":"2","key":"1555_CR55","first-page":"gmr.15027616","volume":"15","author":"J Huang","year":"2016","unstructured":"Huang J, Hou FL, Zhang AY, Li ZL. Protective effect of the polarity of macrophages regulated by IL-37 on atherosclerosis. Genet Mol Res. 2016;15(2):gmr.15027616.","journal-title":"Genet Mol Res"},{"issue":"6","key":"1555_CR56","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1586\/17476348.2015.1109452","volume":"9","author":"L Lunding","year":"2015","unstructured":"Lunding L, Schroder A, Wegmann M. Allergic airway inflammation: unravelling the relationship between IL-37, IL-18R\u03b1 and Tir8\/SIGIRR. Expert Rev Respir Med. 2015;9(6):739\u201350.","journal-title":"Expert Rev Respir Med"},{"issue":"42","key":"1555_CR57","doi-asserted-by":"publisher","first-page":"15178","DOI":"10.1073\/pnas.1416714111","volume":"111","author":"Y Luo","year":"2014","unstructured":"Luo Y, Cai X, Liu S, Wang S, Nold-Petry CA, Nold MF, Bufler P, Norris D, Dinarello CA, Fujita M. Suppression of antigen-specific adaptive immunity by IL-37 via induction of tolerogenic dendritic cells. Proc Natl Acad Sci U S A. 2014;111(42):15178\u201383.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"11","key":"1555_CR58","doi-asserted-by":"publisher","first-page":"e1004462","DOI":"10.1371\/journal.ppat.1004462","volume":"10","author":"S Moretti","year":"2014","unstructured":"Moretti S, Bozza S, Oikonomou V, Renga G, Casagrande A, Iannitti RG, Puccetti M, Garlanda C, Kim S, Li S, et al. IL-37 inhibits inflammasome activation and disease severity in murine aspergillosis. PLoS Pathog. 2014;10(11):e1004462.","journal-title":"PLoS Pathog"},{"issue":"1","key":"1555_CR59","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.cyto.2014.11.025","volume":"72","author":"HM Chen","year":"2015","unstructured":"Chen HM, Fujita M. IL-37: a new player in immune tolerance. Cytokine. 2015;72(1):113\u20134.","journal-title":"Cytokine"},{"issue":"10","key":"1555_CR60","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1111\/1346-8138.13888","volume":"44","author":"T Takeichi","year":"2017","unstructured":"Takeichi T, Watanabe N, Muro Y, Teshigawara S, Sato M, Ban N, Akiyama M. Phosphorylated signal transducer and activator of transcription 3 in the epidermis in adult-onset Still\u2019s disease. J Dermatol. 2017;44(10):1172\u20135.","journal-title":"J Dermatol"}],"container-title":["Arthritis Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-018-1555-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13075-018-1555-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-018-1555-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,31]],"date-time":"2020-10-31T00:34:06Z","timestamp":1604104446000},"score":1,"resource":{"primary":{"URL":"https:\/\/arthritis-research.biomedcentral.com\/articles\/10.1186\/s13075-018-1555-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,22]]},"references-count":60,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["1555"],"URL":"https:\/\/doi.org\/10.1186\/s13075-018-1555-6","relation":{},"ISSN":["1478-6362"],"issn-type":[{"value":"1478-6362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,3,22]]},"assertion":[{"value":"19 November 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 February 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 March 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Authors\u2019 information"}},{"value":"This study was performed in accordance with the Declaration of Helsinki and the principles of good clinical practice. Biological samples were obtained under a protocol approved by the Institutional Research Ethics Committee of Ruijin Hospital (identifier 2016-62), Shanghai, China. All subjects gave written informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"54"}}